Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
FDA Issues Baxter Infusion Pump Recall Requirements July 14, 2010 Staff Writers Add Your Comments The FDA has laid out requirements for the recall of Colleague Volumetric Infusion pumps by Baxter Healthcare Corp., instructing the company on how to refund or provide replacements for about 200,000 potentially dangerous infusion pumps. The FDA announced the infusion pump recall requirements on Tuesday, a little more than two months after it announced that Baxter would be forced to take its Colleague pump off of the market. Problems with Baxter Colleague infusion pumps have been linked to more than 500 deaths and 56,000 reports of adverse events. The electronic infusion pumps are used to deliver medications or other fluids in controlled amounts to patients through epidural, intra-arterial (IA), intravenous (IV), and other methods of administration. The sophisticated devices monitor several sensors, medical-control software and electronics during therapy and automatically sound an alarm and shut down in a potentially harmful situation. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The recall requirements issued this week indicate that Baxter must provide a transition guide to help customers deal with the effects of the recall. The guide will include recommendations on how to minimize treatment disruptions and patient risks, a list of FDA-approved alternative pumps, and information on obtaining refunds or replacements and lease termination programs. The FDA has identified serious flaws with the Colleague pumps since 1999, and there have been a number of Class 1 Baxter infusion pump recalls issued regarding problems with data errors, batteries, and power problems. A Class 1 recall is the most serious category of medical device recall, and is only issued when there is a high probability of severe injury or death to users. In 2006, the FDA obtained a court order halting the production of the infusion pumps until Baxter addressed some of the problems. So far, the company has failed to do so to FDA’s satisfaction. The FDA ordered the company to conduct the recall after Baxter proposed a plan that would not have addressed serious issues with the pump until 2013. The FDA called the plan “unacceptable” as it left potentially dangerous infusion pumps on the market for another three years. The 2006 consent decree gave the FDA the power to take whatever action it felt appropriate to protect the public from the pumps, leading to this week’s recall. The requirements will mean that Baxter will have to provide replacement parts and batteries for the pumps for up to 24 months, until the transition to other pumps has been completed. The recall, replacements and refunds are expected to be completed by July 14, 2012. The FDA launched a new infusion pump safety initiative in April. The new initiative requires manufacturers to undergo more risk assessments before gaining approval for new or modified devices, and they will be expected to submit additional design and engineering information for premarket approval. The new guidance comes following an FDA advisory panel meeting in March, which was called by regulatory agency due to a disturbing trend in the quality of infusion pumps. According to FDA, there have been 56,000 adverse event reports from people reporting problems with infusion sets in the last five years. In addition, there were 87 infusion pump recalls announced between 2005 and 2009. Last summer, a Medtronic Paradigm insulin pump Quick Set Infusion Set recall was issued after the company determined that about 60,000 infusion sets used with the pumps were defective and could give too much insulin to users due to an air pressure problem. Tags: Baxter, Baxter Recall, Infusion Pump, Medical Device More Lawsuit Stories More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025 AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025 Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025) Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024) Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies April 17, 2025
AngioDynamics SmartPort Infection Resulted in Removal of Failed Port Catheter: Lawsuit April 17, 2025
Allstate Driving Data Collection Lawsuits Consolidated in Northern District of Illinois April 17, 2025
More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (Posted: today) Nearly a dozen different cosmetics companies face more than 12,000 hair relaxer lawsuits, involving claims that chemical straighteners caused women to develop uterine cancer, endometrial cancer, ovarian cancer and other injuries. MORE ABOUT: HAIR RELAXER LAWSUITUterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)Schedule for Hair Relaxer Lawsuit Bellwether Trials Outlined by MDL Judge (03/13/2025)Synthetic Braiding Hair Contains Cancer-Causing Chemicals: Consumer Reports (03/05/2025)
Paraquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (Posted: yesterday) Lawyers involved in Paraquat Parkinson’s disease lawsuits pending in the federal court system indicate that they have reached an agreement to settle many of the claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSAppeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)Farmers Exposed to Certain Pesticides Face an Increased Risk of Rheumatoid Arthritis (12/11/2024)
Status of Suboxone Tooth Loss Lawsuits To Be Reviewed at MDL Conference (Posted: yesterday) A federal judge will meet with lawyers involved with Suboxone tooth loss lawsuits tomorrow, to review the status of pretrial proceedings in claims brought by individuals throughout the U.S. MORE ABOUT: SUBOXONE TOOTH DECAY LAWSUITPrenatal Opioid Exposure May Result in Smaller Brains Among Newborns: Study (04/14/2025)Suboxone Lawsuit Filing Deadline Nears for Many Tooth Decay Claims in 3-Year SOL States (04/07/2025)Up to 100 Suboxone Tooth Decay Claims Can Be Filed on Single Lawsuit in MDL: Judge (03/17/2025)